Kirsten Drejer
Director/Board Member at ZEALAND PHARMA A/S
Net worth: 804 875 $ as of 2024-04-29
Network origin in Kirsten Drejer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 55 | |
| Public Company | Pharmaceuticals: Major | 35 | |
| Public Company | Biotechnology | 21 | |
International N&H Denmark ApS
 International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark
18
| Subsidiary | Food: Major Diversified | 18 |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
14
| Public Company | Medical Specialties | 14 |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway.
11
| Extinct | Pharmaceuticals: Other | 11 |
| Public Company | Biotechnology | 11 | |
Bioneer A/S
 Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
| Public Company | Medical Specialties | 9 | |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors.
6
| Private Company | Pharmaceuticals: Major | 6 |
Antag Therapeutics ApS
 Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark.
5
| Holding Company | Pharmaceuticals: Major | 5 |
The Danish Green Growth Fund
2
| Foundation/Endowment | Investment Trusts/Mutual Funds | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kirsten Drejer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Masters Business Admin Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin | |
| University of Copenhagen | College/University | Chairman Graduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| University of Lund | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Masters Business Admin Doctorate Degree | |
| Technical University of Denmark | College/University | Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Masters Business Admin Graduate Degree Graduate Degree Doctorate Degree | |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chairman | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal President Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Founder Chairman Investor Relations Contact Director/Board Member Director/Board Member | |
| University of Aarhus | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
| SYNACT PHARMA AB | Pharmaceuticals: Major | Director of Finance/CFO Chairman Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| A Bioscience Incentive AB | Chairman Chairman Director/Board Member Director/Board Member | ||
| H. LUNDBECK A/S | Pharmaceuticals: Major | Director/Board Member Public Communications Contact Director/Board Member Director/Board Member | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Founder | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Rigshospitalet
 Rigshospitalet Hospital/Nursing ManagementHealth Services Rigshospitalet is a highly specialized hospital in Denmark that ensures all patients in Denmark have a treatment offer, no matter how rare or complicated their illness is. The hospital is located on Blegdamsvej and in Glostrup. Rigshospitalet prioritizes research and achieves and disseminates results through extensive national and international cooperation. The hospital has subsidiaries in Denmark. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
| INNATE PHARMA | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member | |
| Yale University | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| Scandinavian International Management Institute | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member Director of Finance/CFO Chief Executive Officer | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | Director/Board Member Founder Investor Relations Contact | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Human Resources Officer | |
| NNIT A/S | Information Technology Services | Chairman Director/Board Member Corporate Officer/Principal | |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | President Director of Finance/CFO | |
PainDrainer AB
 PainDrainer AB Packaged SoftwareTechnology Services PainDrainer AB is a Swedish medical technology company that helps people with chronic pain achieve a better quality of life and activity balance. The company is based in Lund, Sweden. The company's app is based on seven categories that have a scientifically proven impact on pain levels. Users can choose what they want to do more of in their lives, and the app helps them achieve their goals. PainDrainer has been shown to have a scientifically documented effect in many clinical studies and is a CE-marked medical technical app. The CEO of the company is Erik Frick. | Packaged Software | Chairman Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
TRT Innovations ApS
 TRT Innovations ApS BiotechnologyHealth Technology Part of Curasight A/S, TRT Innovations ApS is a research and Danish development company. The company is based in Copenhagen, Denmark. The company was founded in 2015 by Andreas Kjær and Morten Persson. The CEO is Ulrich A. Krasilnikoff. TRT Innovations was acquired by Curasight A/S from AK 2014 Holding ApS on February 10, 2022 for $1.14 million. | Biotechnology | Chief Executive Officer Founder | |
| IMMUNOVIA AB | Pharmaceuticals: Major | Founder Director/Board Member | |
| AMBU A/S | Medical Specialties | Director/Board Member Chief Executive Officer | |
NNE A/S
 NNE A/S Engineering & ConstructionIndustrial Services Part of Novo Nordisk A/S, NNE A/S is a Danish company that supplies systems, consultancy and engineering services. The company is based in Soborg, Denmark. | Engineering & Construction | Director/Board Member Chairman | |
Reliance A/S
 Reliance A/S Miscellaneous Commercial ServicesCommercial Services Reliance A/S provides business consulting services. The company also provides services to the public and initial public offering companies. It offers advices in the areas such as investor relations, corporate finance, equity research, communication and operational and strategic issues. Reliance is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Medical Specialties | Director/Board Member Chief Executive Officer | |
| SANOFI | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ALK-ABELLÓ A/S | Biotechnology | Chief Executive Officer Director/Board Member | |
Dansk Erhverv
 Dansk Erhverv Miscellaneous Commercial ServicesCommercial Services Dansk Erhverv is a business organization and employer association representing one of the world's most powerful business communities. The private company is based in Copenhagen, Denmark, and has subsidiaries in Denmark. With a membership of 18,000 companies and over 100 industry associations, the organization works daily to promote Denmark as the best country in the world to do business. The Danish company was founded by Tom Sten Behrens-Sørensen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Copenhagen Capacity
 Copenhagen Capacity Financial ConglomeratesFinance Copenhagen Capacity provides investment promotion and economic development services. The private company is based in Copenhagen, Denmark. Asbjørn Overgaard Christiansen has been the CEO of the Danish company since 2020. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| TXP Pharma GmbH | Chief Executive Officer Founder | ||
Bioporto Diagnostics A/S
 Bioporto Diagnostics A/S BiotechnologyHealth Technology Part of Bioporto A/S, Bioporto Diagnostics A/S is a Danish company that engages in research and experimental development on biotechnology. The company is based in Gentofte, Denmark. Peter Morch Eriksen has been the CEO of the company since 2013. | Biotechnology | Director/Board Member Director/Board Member |
Statistics
International
| Denmark | 25 |
| Sweden | 13 |
| United States | 8 |
| United Kingdom | 4 |
| France | 4 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Finance | 3 |
| Technology Services | 3 |
Operational
| Director/Board Member | 620 |
| Corporate Officer/Principal | 189 |
| Chairman | 165 |
| Independent Dir/Board Member | 147 |
| Chief Executive Officer | 107 |
Most connected contacts
- Stock Market
- Insiders
- Kirsten Drejer
- Company connections
